ClinicalTrials.gg
RecruitingNCT06079216MCTMUpdated Sep 15, 2026

Making Connections Thru Music

An interventional study of Volunteer Led Making Connections Thru Music and Staff Led Making Connections Thru Music in Dementia, Alzheimer Disease and Vascular Dementia, sponsored by Hopeful Aging. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 103 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Hopeful Aging · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
196
Allocation
Randomized
Ages
18 Years to 103 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,051 studies in Dementia with a site in United States — 211 open to participants now, 276 under way, 15 of them phase 3. Dementia · United States.

Planned enrollment
286th of 846
196 · median 93
Started
2025
with 60 others
No phase
562 of 1,051
118 open now
Primary completion
2027-04
later than 121 of 275 live
Registered
840th of 1,051
by date

Among the 1,051 studies in Dementia with a site in United States, this one is the 286th largest by planned enrollment of the 846 interventional ones that give a count, is one of 61 that started in 2025, is one of 562 with no phase, reaches primary completion later than 121 of the 275 other live ones, and was the 840th registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

211 of the 1,051 studies in Dementia with a site in United States are open now. Recruiting first, the newest first:

206 more — sign in →

All 211 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 18 Years to 103 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,051 studies in Dementia with a site in United States, or all of them as a file.
02

Study summary

Healthcare systems around the world, including within the United States, have long-established shortages of trained caregivers. The American Health Care Association states that "the health care system has experienced a shortage of trained caregivers for critical roles for some time." This scarcity directly impacts the 45,800 Long-Term Care (LTC) communities throughout the U.S.

Concurrent with this staff shortage, more than half of LTC residents have some form of dementia. These two issues create a serious public health concern, since dementia is associated with a variety of behavioral expressions, such as aggression, anxiety, and agitation. Behavioral expressions of dementia can be successfully managed with the use of tailored, psychosocial interventions and communication support. Unfortunately, existing staff shortages make the facilitation of such interventions challenging.

One powerful and often-overlooked approach to ameliorating staffing shortages involves the utilization of retired volunteers to facilitate interventions for persons with dementia (PWD). Based on the nearly universal love of music and a promising pilot study, the product to be developed and tested in this STTR will build upon the combined prior work of the Principal Investigators. Making Connections Thru Music (MCTM), an urgently needed product, will enable retired volunteers to facilitate an evidence-based music and discussion intervention with PWD. MCTM aims to improve engagement, enhance quality of life, and reduce behavioral expressions in PWD. The intervention will consist of two main components: (1) a comprehensive online training course for volunteers, which will provide a general overview of dementia, demonstrate effective communication strategies to use with PWD, and instruct volunteers to effectively facilitate MCTM sessions, and (2) an app containing a structured MCTM intervention protocol and toolkit, which will be the means by which volunteers facilitate MCTM. MCTM will be marketed to LTC communities.

03

Conditions studied

  • Dementia
  • Alzheimer Disease
  • Vascular Dementia
04

Who can participate

Ages eligible
18 Years to 103 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteers must be aged 55+ and speak/read conversational English.
  • Staff participants must be at least 18 years old, work within a residential care facility participating in the study, and speak and read English.

Exclusion criteria

Exclusion Criteria:

  • Volunteers will be excluded if they are diagnosed with dementia based on self-report and/or if they score 23 or lower on theMini Mental State Exam (; Folstein et al., 1975). Such a score would be indicative of possible cognitive impairment.
  • Staff members will be excluded if they work third shift only. PWD Residents with dementia must be diagnosed with dementia (any type), score 10 or above on the MMSE, be aged 65+, and speak/read conversational English.
  • PWD will be excluded if they show signs of rapid physical or cognitive decline (based upon staff report or as evidenced by information gained during screening).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
196 participants (estimated)

Study arms

  • Experimental
    MCTM Intervention

    Activity sessions will be led by activity volunteers

    Behavioral: Volunteer Led Making Connections Thru Music

  • Active comparator
    Control

    Activity sessions will be led by activity professionals

    Behavioral: Staff Led Making Connections Thru Music

Interventions

  • BehavioralVolunteer Led Making Connections Thru Music

    Volunteer led Group music therapy-based intervention

  • BehavioralStaff Led Making Connections Thru Music

    Staff led Group music therapy-based intervention

06

What researchers measure

Primary outcomes

  1. Menorah Park Engagement Scale

    The MPES is an observational scale that measures four types of engagement: Constructive Engagement, Passive Engagement, Distracted Engagement, and Non-Engagement / Apathy The MPES also measures Pleasure, defined as clearly observable smiling or laughing. For each item, the minimum possible value is 0 (not at all) and the maximum possible value is 2 (more than half of the time). For Constructive Engagement, Passive Engagement, and Pleasure, higher scores would represent a better outcome. For Distracted Engagement and Non-Engagement, higher scores would represent a worse outcome.

    Time frame: Baseline (weeks 1-4) Treatment (weeks 5-12)

Secondary outcomes

  1. Alzheimer's Disease Knowledge Scale

    30-item scale to measure knowledge of Alzheimer's Disease. The range of score is zero to 30. A higher score indicates a better outcome.

    Time frame: Baseline (weeks 1-4) Treatment (weeks 5-12)

  2. Geriatric Depression Scale- Short Form. Scores can range from zero to 15. Higher scores suggest a worse outcome

    This is a 15-item measure of depression in older adults that is conducted via direct interview.

    Time frame: Baseline (weeks 1-4) Treatment (weeks 5-12)

  3. Neuropsychiatric Inventory - Nursing Home.

    The Neuropsychiatric Inventory-Nursing Home is a comprehensive assessment of psychopathology in persons with dementia, focused on people residing in nursing homes. Researchers typically use the frequency x severity (FxS) total score on this measure. We will be using this score in this study. The FxS score ranges from 0 to 120, with a higher score indicating a worse outcome.

    Time frame: Baseline (weeks 1-4) Treatment (weeks 5-12)

07

Study locations

2 of 2 sites recruiting
  • Hopeful Aging
    Winchester, Massachusetts 01890, United States
    Recruiting
    • Michael Skrajner · Contactmike@hopefulaging.com · 440-477-7881
    • Gregg Gorzelle, MA · Principal investigator
  • The Hearthstone Institute, LLC
    Winchester, Massachusetts 01890, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Apr 2027, 16 months after the start.

Of 46 industry-sponsored interventional studies with no phase under Dementia, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's planned 16 months is close to that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2023
First posted
Oct 12, 2023
StartActual
Dec 1, 2025
Primary completionEst.
Apr 29, 2027
CompletionEst.
Apr 30, 2027
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06079216
Lead sponsor
Hopeful Aging
Collaborators
Benjamin Rose Institute on Aging
Responsible party
Gregg Gorzelle (Associate Director of Research, Hopeful Aging) — Principal investigator
First posted
Oct 12, 2023
Start date
Dec 1, 2025
Primary completion
Apr 29, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Sep 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion